Cva Family Office, LLC Astrazeneca PLC Transaction History
Cva Family Office, LLC
- $550 Million
- Q2 2024
A detailed history of Cva Family Office, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cva Family Office, LLC holds 1,007 shares of AZN stock, worth $79,069. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,007
Previous 1,007
-0.0%
Holding current value
$79,069
Previous $68,000
14.71%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,278Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.81 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.86 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.37 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.71 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.36 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $243B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...